Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Waldenstrom Macroglobulinemia
×
bazlitoran
×
Clear all
Filters
3
NCT02092909
2019-09-10
8400-401
Idera Pharmaceuticals, Inc.
Phase 1/2
Terminated
31 enrolled
18 charts